 The expert panel concluded that benzodiazepines should not be used as a first-line option for treating unspecified anxiety disorders. Instead, they recommended various non-pharmacologic interventions such as cognitive behavioral therapy, psychoeducation, lifestyle changes, relaxation techniques, and differential diagnosis. Additionally, if the patient does not respond well to these treatments, then switching to selective serotonin reuptake inhibitor, SSRI, and medications may be considered. This article was authored by Hitoshi Sakurai, Keninata, Yumi Aoki, and others.